GPR40 is expressed in glucagon producing cells and affects glucagon secretion

Biochemical and Biophysical Research Communications

Volumn 354, Issue 1, 2007, Pages 240-245

  Flodgren, Erik ^a   Olde, Björn ^b   Meidute Abaraviciene, Sandra ^c   Winzell, Maria Sörhede ^a   Ahrén, Bo ^a   Salehi, Albert ^c  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cell; Diabetes; Free fatty acid; Glucagon; GPR40; Pancreatic islets

Indexed keywords

FATTY ACID; GLUCAGON; INSULIN; LINOLEIC ACID; PHOSPHATIDYLINOSITOL; PROTEIN GPR40; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FUNCTIONAL PROTEOMICS; GLUCAGON RELEASE; GLUCAGONOMA; HAMSTER; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HYDROLYSIS; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAINING; TUMOR CELL;

ANIMALS; CELLS, CULTURED; CRICETINAE; FEMALE; GLUCAGON; GLUCAGON-SECRETING CELLS; MICE; RECEPTORS, G-PROTEIN-COUPLED;

CRICETINAE;

EID: 33846327180     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.193     Document Type: Article

References (20)

1. Briscoe C.P., Tadayyon M., Andrews J.L., Benson W.G., Chambers J.K., Eilert M.M., Ellis C., Elshourbagy N.A., Goetz A.S., Minnick D.T., Murdock P.R., Sauls Jr. H.R., Shabon U., Spinage L.D., Strum J.C., Szekeres P.G., Tan K.B., Way J.M., Ignar D.M., Wilson S., and Muir A.I. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278 (2003) 11303-11311
2. Itoh Y., Kawamata Y., Harada M., Kobayashi M., Fujii R., Fukusumi S., Ogi K., Hosoya M., Tanaka Y., Uejima H., Tanaka H., Maruyama M., Satoh R., Okubo S., Kizawa H., Komatsu H., Matsumura F., Noguchi Y., Shinohara T., Hinuma S., Fujisawa Y., and Fujino M. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422 (2003) 173-176
3. Kotarsky K., Nilsson N.E., Flodgren E., Owman C., and Olde B. A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. Biochem. Biophys. Res. Commun. 301 (2003) 406-410
4. Salehi A., Flodgren E., Nilsson N.E., Jimenez-Feltstrom J., Miyazaki J., Owman C., and Olde B. Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion. Cell Tissue Res. 322 (2005) 207-215
5. Steneberg P., Rubins N., Bartoov-Shifman R., Walker M.D., and Edlund H. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab. 1 (2005) 245-258
6. Shapiro H., Shachar S., Sekler I., Hershfinkel M., and Walker M.D. Role of GPR40 in fatty acid action on the beta cell line INS-1E. Biochem. Biophys. Res. Commun. 335 (2005) 97-104
7. Bollheimer L.C., Landauer H.C., Troll S., Schweimer J., Wrede C.E., Scholmerich J., and Buettner R. Stimulatory short-term effects of free fatty acids on glucagon secretion at low to normal glucose concentrations. Metabolism 53 (2004) 1443-1448
8. Hong J., Abudula R., Chen J., Jeppesen P.B., Dyrskog S.E., Xiao J., Colombo M., and Hermansen K. The short-term effect of fatty acids on glucagon secretion is influenced by their chain length, spatial configuration, and degree of unsaturation: studies in vitro. Metabolism 54 (2005) 1329-1336
9. Olofsson C.S., Salehi A., Gopel S.O., Holm C., and Rorsman P. Palmitate stimulation of glucagon secretion in mouse pancreatic alpha-cells results from activation of L-type calcium channels and elevation of cytoplasmic calcium. Diabetes 53 (2004) 2836-2843
10. Kang D.S., and Leeb-Lundberg L.M. Negative and positive regulatory epitopes in the C-terminal domains of the human B1 and B2 bradykinin receptor subtypes determine receptor coupling efficacy to G(q/11)-mediated phospholipase Cβ activity. Mol. Pharmacol. 62 (2002) 281-288
11. Campillo J.E., Luyckx A.S., and Lefebvre P.J. Effect of oleic acid on arginine-induced glucagon secretion by the isolated perfused rat pancreas. Acta Diabetol. Lat. 16 (1979) 287-293
12. Madison L.L., Seyffert Jr. W.A., Unger R.H., and Barker B. Effect on plasma free fatty acids on plasma glucagon and serum insulin concentrations. Metabolism 17 (1968) 301-304
13. Tomita T., Masuzaki H., Noguchi M., Iwakura H., Fujikura J., Tanaka T., Ebihara K., Kawamura J., Komoto I., Kawaguchi Y., Fujimoto K., Doi R., Shimada Y., Hosoda K., Imamura M., and Nakao K. GPR40 gene expression in human pancreas and insulinoma. Biochem. Biophys. Res. Commun. 338 (2005) 1788-1790
14. Larsson L.I., Sundler F., and Hakanson R. Pancreatic polypeptide-a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia 12 (1976) 211-226
15. Orci L., Baetens D., Ravazzola M., Stefan Y., and Malaisse-Lagae F. Pancreatic polypeptide and glucagon: non-random distribution in pancreatic islets. Life Sci. 19 (1976) 1811-1815
16. De Lean A., Stadel J.M., and Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J. Biol. Chem. 255 (1980) 7108-7117
17. Salehi A., Vieira E., and Gylfe E. Paradoxical stimulation of glucagon secretion by high glucose concentrations. Diabetes 55 (2006) 2318-2323
18. Summerton J., and Weller D. Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev. 7 (1997) 187-195
19. Gaborik Z., and Hunyady L. Intracellular trafficking of hormone receptors. Trends Endocrinol. Metab. 15 (2004) 286-293
20. Unger R.H. Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism 27 (1978) 1691-1709